Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Antitumor heterocyclic compounds from Takeda

Feb. 20, 1997

New paclitaxel combination demonstrates enhanced efficacy

Feb. 19, 1997

Antiproliferative agents from Pfizer

Feb. 19, 1997

Sugen continues to focus on TK inhibitors

Feb. 19, 1997

Aphton and Pasteur Merieux Connaught form immunotherapy product alliance

Feb. 18, 1997

AEterna clarifies Neovastat clinical development program

Feb. 18, 1997

Mechanism of antitumor effect of natural lipopolysaccharide

Feb. 18, 1997

Progen's lead compound shows promise for cancer/metastasis

Feb. 18, 1997

Apoptosis-regulating factor discovered

Feb. 17, 1997

Chiron prepares uPA inhibitors

Feb. 17, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 20, 2026.
ALN-5288 lowers tau levels in preclinical models
BioWorld Science
Pathological tau accumulation is a key driver of neurodegeneration in Alzheimer’s disease (AD) and other tauopathies such as progressive supranuclear palsy....
Capital remains selective in ‘barbell’ biotech market
BioWorld
Signs of recovery are emerging in the biotechnology investment sector, although investors across Asia say that capital is flowing selectively to companies that...
Dual FAAH/MAGL inhibition targets Alzheimer’s disease hyperexcitability
BioWorld Science
Reduced endocannabinoid signaling has been linked to neuronal hyperexcitability in Alzheimer’s disease (AD), suggesting that dual inhibition of fatty acid amide...
PSB-229 reduces plaque burden in Alzheimer’s models
BioWorld Science
Pyroglutamate-modified amyloid-β (pE3-Aβ) is a highly pathogenic Aβ species that accumulates within amyloid plaques and contributes to aggregation,...